EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Artificial Intelligence in the Screening, Diagnosis, and Management of Aortic Stenosis

Yuxuan Zhang, Moyang Wang, Erli Zhang, Yongjian Wu

Reviews in Cardiovascular Medicine · 17.01.2024 · 25 (1)

DOI: 10.31083/j.rcm2501031 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 17.01.2024. Verfasst von Yuxuan Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academ…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The integration of artificial intelligence (AI) into clinical management of aortic stenosis (AS) has redefined our approach to the assessment and management of this heterogenous valvular heart disease (VHD). While the large-scale early detection of valvular conditions is limited by socioeconomic constraints, AI offers a cost-effective alternative solution for screening by utilizing conventional tools, including electrocardiograms and community-level auscultations, thereby facilitating early detection, prevention, and treatment of AS. Furthermore, AI sheds light on the varied nature of AS, once considered a uniform condition, allowing for more nuanced, data-driven risk assessments and treatment plans. This presents an opportunity to re-evaluate the complexity of AS and to refine treatment using data-driven risk stratification beyond traditional guidelines. AI can be used to support treatment decisions including device selection, procedural techniques, and follow-up surveillance of transcatheter aortic valve replacement (TAVR) in a reproducible manner. While recognizing notable AI achievements, it is important to remember that AI applications in AS still require collaboration with human expertise due to potential limitations such as its susceptibility to bias, and the critical nature of healthcare. This synergy underpins our optimistic view of AI’s promising role in the AS clinical pathway.

Schlagwörter

Stichwörter der Autor:innen

TAVRaortic stenosisartificial intelligencerisk stratificationscreeningsurveillance

Autor:innen und Institutionen

  • Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037 Beijing…
  • Center for Structural Heart Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 10…

Förderung

  • National Key R&D Program of China

Zitieren

APA

Zhang, Y., Wang, M., Zhang, E., & Wu, Y. (2024). Artificial Intelligence in the Screening, Diagnosis, and Management of Aortic Stenosis. Reviews in Cardiovascular Medicine, 25(1). https://doi.org/10.31083/j.rcm2501031

Vancouver

Zhang Y, Wang M, Zhang E, Wu Y. Artificial Intelligence in the Screening, Diagnosis, and Management of Aortic Stenosis. Reviews in Cardiovascular Medicine. 2024;25(1). doi:10.31083/j.rcm2501031

BibTeX
@article{Zhang2024,
  author = {Zhang, Yuxuan and Wang, Moyang and Zhang, Erli and Wu, Yongjian},
  title = {Artificial Intelligence in the Screening, Diagnosis, and Management of Aortic Stenosis},
  journal = {Reviews in Cardiovascular Medicine},
  year = {2024},
  volume = {25},
  number = {1},
  doi = {10.31083/j.rcm2501031}
}
Kostenlos starten →